<DOC>
	<DOCNO>NCT00795873</DOCNO>
	<brief_summary>Post approval study measure safety outcome Ovatio CRT-D SITUS OTW LV lead 5 year .</brief_summary>
	<brief_title>OVATIO CRT SITUS OTW LV Lead Post Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>NYHA Class III/IV Stable medical regimen QRS great equal 130 m LVEF le equal 35 % VT transient reversible cause Incessant VT Currently implant lead position coronary sinus ( unless SITUS OTW LV lead ) Cardiac revascularization angioplasty within last month Heart failure due correctable valve disease Chronic , medially refractory AT Enrolled another clinical study may confound result study Life expectancy le 6 month Inability understand purpose study refusal cooperate Inability refusal provide inform consent Unavailable schedule followup implanting practice Sensitivity 1 mg dexamethasone sodium phosphate Less 18 year age Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>cardiac resynchronization therapy</keyword>
</DOC>